Lista de obras - Andrea Napolitano - Dominio Público Uruguay

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations

artículo científico publicado en 2018

Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression

artículo científico publicado en 2015

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

artículo científico publicado en 2012

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation

artículo científico publicado en 2017

Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin

artículo científico publicado en 2018

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s

artículo científico publicado en 2015

Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression

artículo científico publicado en 2015

Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling

artículo científico publicado en 2013

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

artículo científico publicado en 2010

Evaluation of clonal origin of malignant mesothelioma

artículo científico publicado en 2014

Evidence-based guidelines: Improving AGREEment on consistence evaluation

artículo científico publicado en 2012

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model

artículo científico publicado en 2017

Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis

artículo científico publicado en 2020

Germline BAP1 mutations induce a Warburg effect

artículo científico publicado en 2017

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.

artículo científico publicado en 2016

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

artículo científico publicado en 2017

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

artículo científico publicado en 2018

Improving the Accuracy of Mesothelioma Diagnosis in China

artículo científico publicado en 2016

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.

artículo científico

Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity

artículo científico publicado en 2016

Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients

artículo científico publicado en 2022

Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies

artículo científico publicado en 2015

Malignant Mesothelioma: Time to Translate?

artículo científico publicado en 2016

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

artículo científico publicado en 2014

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma

artículo científico publicado en 2016

New frontiers in the medical management of gastrointestinal stromal tumours.

artículo científico publicado en 2019

Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas

artículo científico publicado en 2017

PDGFRα inhibition in soft-tissue sarcomas: Have we gotten it all wrong?

artículo científico publicado en 2019

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma

artículo científico publicado en 2016

Preclinical development of HIvax: Human survivin highly immunogenic vaccines

artículo científico publicado en 2015

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

artículo científico publicado en 2020

Progress in the Management of Malignant Pleural Mesothelioma in 2017.

artículo científico publicado en 2018

Recent Advances in Desmoid Tumor Therapy

artículo científico publicado en 2020

Secondary KIT mutations: the GIST of drug resistance and sensitivity

scientific article published on 22 February 2019

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

artículo científico publicado en 2012

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma

artículo científico publicado en 2019

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.

artículo científico publicado en 2011

Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordoma

scientific article published on 02 June 2019

Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients

scientific article published on 07 August 2019

Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives

artículo científico publicado en 2010

Lista de obras de Andrea Napolitano

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations

Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation

Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s

Concerns About Presence of a Wild-Type BAP1 Allele in Absence of Nuclear Protein Expression

Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

Evaluation of clonal origin of malignant mesothelioma

Evidence-based guidelines: Improving AGREEment on consistence evaluation

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model

Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis

Germline BAP1 mutations induce a Warburg effect

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

Improving the Accuracy of Mesothelioma Diagnosis in China

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.

Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity

Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients

Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies

Malignant Mesothelioma: Time to Translate?

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma

New frontiers in the medical management of gastrointestinal stromal tumours.

Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas

PDGFRα inhibition in soft-tissue sarcomas: Have we gotten it all wrong?

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma

Preclinical development of HIvax: Human survivin highly immunogenic vaccines

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

Progress in the Management of Malignant Pleural Mesothelioma in 2017.

Recent Advances in Desmoid Tumor Therapy

Secondary KIT mutations: the GIST of drug resistance and sensitivity

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.

Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordoma

Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients

Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives